These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10350122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
    Huang MS, Jong SB, Tsai MS, Lin MS, Chong IW, Lin HC, Hwang JJ.
    Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
    Ebert W, Hoppe M, Muley T, Drings P.
    Anticancer Res; 1997 Mar; 17(4B):2875-8. PubMed ID: 9329552
    [Abstract] [Full Text] [Related]

  • 5. Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Massaron S, Cataldo I, Oldani S, Iurlo A, Caldiera S, Bombardieri E.
    Int J Biol Markers; 1999 Mar; 14(2):92-8. PubMed ID: 10399628
    [Abstract] [Full Text] [Related]

  • 6. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L, Ceriani L, Giardina G, Bardelli D, Tanzi F, Garancini S.
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [Abstract] [Full Text] [Related]

  • 7. Prognosis in bronchogenic squamous cell carcinoma groups divided according to serum squamous cell carcinoma-related antigen and cytokeratin 19 fragment levels.
    Kashiwabara K, Nakamura H, Esaki T.
    Clin Chim Acta; 2000 Apr; 294(1-2):105-13. PubMed ID: 10727677
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, Barak V.
    Anticancer Res; 1999 Apr; 19(4C):3549-52. PubMed ID: 10629651
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
    Song WA, Liu X, Tian XD, Wang W, Liang CY, Zhang T, Guo JT, Peng YH, Zhou NK.
    Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer.
    Bates J, Rutherford R, Divilly M, Finn J, Grimes H, O'Muircheartaigh I, Gilmartin JJ.
    Eur Respir J; 1997 Nov; 10(11):2535-8. PubMed ID: 9426091
    [Abstract] [Full Text] [Related]

  • 15. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Nov; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 16. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors.
    Indinnimeo M, Reale MG, Cicchini C, Stazi A, Fiori E, Izzo P.
    Int Surg; 1997 Nov; 82(3):275-9. PubMed ID: 9372374
    [Abstract] [Full Text] [Related]

  • 17. [Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma].
    Mahler B.
    Pneumologia; 2008 Nov; 57(3):175-7. PubMed ID: 18998332
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers TPA and Cyfra 21.1 in patients with non-small cell lung cancer after surgery and chemotherapy].
    Passowicz-Muszyńska E, Gisterek I, Marciniak M, Kornafel J, Kołodziej J, Jankowska R.
    Pol Merkur Lekarski; 2002 Oct; 13(76):294-7. PubMed ID: 12557434
    [Abstract] [Full Text] [Related]

  • 19. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2004 Oct; 24(3b):1953-6. PubMed ID: 15274383
    [Abstract] [Full Text] [Related]

  • 20. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D, Eleftheriadou A, Chalastras T, Kyriou L, Yiotakis I, Ferekidis E.
    Med Oncol; 2006 Oct; 23(4):463-70. PubMed ID: 17303904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.